PharmaCyte Biotech, Inc. (PMCB) › Cost of RevenuePharmaCyte Biotech, Inc. (PMCB) — Cost of RevenueAnnual figures by period end, from SEC filings.2011-04-30: $32.1K2012-04-30: $19.4K2013-04-30: $9.6K2014-04-30: $02015-04-30: $02016-04-30: $0$02011-04-30Cost of Revenue (USD)2016-04-30Period endedCost of RevenueChange YoYSource filing2016-04-30$0—2016-07-29From 2015-05-012015-04-30$0—2016-07-29From 2014-05-012014-04-30$0-100.0%2016-07-29From 2013-05-012013-04-30$9.6K-50.4%2016-01-19From 2012-05-012012-04-30$19.4K-39.6%2013-07-29From 2011-05-012011-04-30$32.1K—2012-08-14From 2010-05-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)